This Article  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

SHAN R. BAKER, MD
Ann Arbor, Mich

Arch Otolaryngol Head Neck Surg. 1988;114(7):721.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The role of chemotherapy in the management of patients with cancer of the paranasal sinuses is not presently defined. An analysis of 21 patients treated with chemotherapy as part of their overall therapy was reported by Tapazoglou and colleagues from Wayne State University and Harper Grace Hospitals, Detroit. They reported on 14 males and seven females at the Second International Head and Neck Oncology Research Conference. Thirteen patients previously untreated made up group A and eight patients who had presented with recurrent disease after surgery and/or radiotherapy made up group B. Six of the patients in group A had distant metastatic disease on presentation (four, central nervous system [CNS]; two, lung) and four patients in group B had CNS involvement. The majority of the patients (81%) had squamous cell carcinoma. The chemotherapy regimen included cisplatin, oncovin, and bleomycin (COB), or fluorouracil infusion and cisplatin combinations. Computed tomographic scans were used . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?